Progress and Prospects in Pediatric Leukemia

被引：47

作者：

Madhusoodhan, P. Pallavi ^{[1
]}

Carroll, William L. ^{[1
]}

Bhatla, Teena ^{[1
]}

机构：

[1] NYU, Div Pediat Hematol Oncol, Dept Pediat, Perlmutter Canc Ctr,Langone Med Ctr, New York, NY USA

来源：

CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE | 2016年 / 46卷 / 07期

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CENTRAL-NERVOUS-SYSTEM; WORLD-HEALTH-ORGANIZATION; MINIMAL RESIDUAL DISEASE; CHILDHOOD T-CELL; CLINICAL-FEATURES; RELAPSE RISK; MYELOPROLIFERATIVE DISORDER; MYELOMONOCYTIC LEUKEMIA;

D O I：

10.1016/j.cppeds.2016.04.003

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Pediatric leukemia is the single most common malignancy affecting children, representing up to 30% of all pediatric cancers. Dramatic improvements in survival for acute lymphoblastic leukemia (ALL) have taken place over the past 4 decades with outcomes approaching 90% in the latest studies. However, progress has been slower for myeloid leukemia and certain subgroups like infant ALL, adolescent/young adult ALL, and relapsed ALL. Recent advances include recognition of molecularly defined subgroups, which has ushered in precision medicine approaches. We discuss the current understanding of the biology of the various childhood leukemias, recent advances in research, and future challenges in this field.

引用

页码：229 / 241

页数：13

共 101 条

[1]

Advani AS, 2013, 55 ANN ASH M EXP NEW

[2] Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005 [J].

Arico, Maurizio ;

Schrappe, Martin ;

Hunger, Stephen P. ;

Carroll, William L. ;

Conter, Valentino ;

Galimberti, Stefania ;

Manabe, Atsushi ;

Saha, Vaskar ;

Baruchel, Andre ;

Vettenranta, Kim ;

Horibe, Keizo ;

Benoit, Yves ;

Pieters, Rob ;

Escherich, Gabriele ;

Silverman, Lewis B. ;

Pui, Ching-Hon ;

Valsecchi, Maria Grazia .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) :4755-4761

[3]

ASATO R, 1992, CANCER, V70, P1997, DOI 10.1002/1097-0142(19921001)70:7<1997::AID-CNCR2820700732>3.0.CO

[4]

2-G

[5] Occurrence of myeloproliferative disorder in patients with Noonan syndrome [J].

BaderMeunier, B ;

Tchernia, G ;

Mielot, F ;

Fontaine, JL ;

Thomas, C ;

Lyonnet, S ;

Lavergne, JM ;

Dommergues, JP .

JOURNAL OF PEDIATRICS, 1997, 130 (06) :885-889

[6] Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer - An update [J].

Barnard, DR ;

Woods, WG .

LEUKEMIA & LYMPHOMA, 2005, 46 (05) :651-662

[7] Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983 [J].

Bhatia, S ;

Sather, HN ;

Pabustan, OB ;

Trigg, ME ;

Gaynon, PS ;

Robison, LL .

BLOOD, 2002, 99 (12) :4257-4264

[8] The Biology of Relapsed Acute Lymphoblastic Leukemia: Opportunities for Therapeutic Interventions [J].

Bhatla, Teena ;

Jones, Courtney L. ;

Meyer, Julia A. ;

Vitanza, Nicholas A. ;

Raetz, Elizabeth A. ;

Carroll, William L. .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (06) :413-418

[9] Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia [J].

Bhatla, Teena ;

Wang, Jinhua ;

Morrison, Debra J. ;

Raetz, Elizabeth A. ;

Burke, Michael J. ;

Brown, Patrick ;

Carroll, William L. .

BLOOD, 2012, 119 (22) :5201-5210

[10] Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].

Bonnet, D ;

Dick, JE .

NATURE MEDICINE, 1997, 3 (07) :730-737

← 1 2 3 4 5 6 7 8 9 10 →